A template image of dopamine D2 receptor density was derived from 6 PET scans in healthy volunteers using the high affinity D2/D3 antagonist ligand [18F]-Fallypride. Brain mRNA expression values for DRD2 gene (coding for D2R) were extracted from the ABA dataset by using the MENGA toolbox. CBF contrast images and the [18F]Fallypride BPND template were segmented into 83 ROIs by using the Desikan-Killiany Atlas. The regional changes in CBF against placebo (∆CBF) were compared with regional BPND values and gene expression maps using multivariate correlations. Results: For all antipsychotics, CBF changes in each ROI were directly proportional to [18F]Fallypride non displaceable binding potential (BPND) values (OLA R2= 0.24, HAL R2= 0.61, lowRIS R2= 0.54, highRIS R2= 0.52, all p<0.001) and DRD2 mRNA expression levels (OLA R2= 0.04, HAL R2= 0.15, lowRIS R2= 0.19, highRIS R2= 0.20, all chance likelihood <2%). Discussion: In the present study, we were able to show that the CBF increase induced by antipsychotic is directly proportional to D2R concentration in the brain, as indexed by PET BPND maps and mRNA expression levels. Interestingly, the association strength between ∆CBF and brain receptor distribution profiles mirrored differential D2R affinity between the tested drugs. Overall, these results indicate that CBF increases after administration of a single dose of antipsychotics actually reflect known pharmacodynamics profile of these compounds. In addition, these results further reinforce previous evidence suggesting the role of D2R blockade as a mechanism behind increased CBF induced by antipsychotics. Finally, CBF is ultimately a functional marker and this work is important in bridging the considerable gap between the pharmacokinetic and pharmacodynamic effects of compounds with unclear brain functional effects like antipsychotics. Background: Studies using the event sampling method (ESM), a structured diary technique measuring subjective experiences and emotional fluctuations in daily life, have consistently shown that individuals reporting psychotic experiences display a heightened emotional reactivity to minor stressors-a neuropsychological mechanism that likely contributes to the development and perpetuation of psychotic experiences. Except a few undersized non-replicated candidate-gene studies showing an association between genetic variations and elevated momentary stress reactivity, genetic underpinnings of emotion reactivity to momentary stressors have
A template image of dopamine D2 receptor density was derived from 6 PET scans in healthy volunteers using the high affinity D2/D3 antagonist ligand [18F]-Fallypride. Brain mRNA expression values for DRD2 gene (coding for D2R) were extracted from the ABA dataset by using the MENGA toolbox. CBF contrast images and the [18F]Fallypride BPND template were segmented into 83 ROIs by using the Desikan-Killiany Atlas. The regional changes in CBF against placebo (∆CBF) were compared with regional BPND values and gene expression maps using multivariate correlations. Results: For all antipsychotics, CBF changes in each ROI were directly proportional to [18F] Fallypride non displaceable binding potential (BPND) values (OLA R2= 0.24, HAL R2= 0.61, lowRIS R2= 0.54, highRIS R2= 0.52, all p<0.001) and DRD2 mRNA expression levels (OLA R2= 0.04, HAL R2= 0.15, lowRIS R2= 0.19, highRIS R2= 0.20, all chance likelihood <2%). Discussion: In the present study, we were able to show that the CBF increase induced by antipsychotic is directly proportional to D2R concentration in the brain, as indexed by PET BPND maps and mRNA expression levels. Interestingly, the association strength between ∆CBF and brain receptor distribution profiles mirrored differential D2R affinity between the tested drugs. Overall, these results indicate that CBF increases after administration of a single dose of antipsychotics actually reflect known pharmacodynamics profile of these compounds. In addition, these results further reinforce previous evidence suggesting the role of D2R blockade as a mechanism behind increased CBF induced by antipsychotics. Finally, CBF is ultimately a functional marker and this work is important in bridging the considerable gap between the pharmacokinetic and pharmacodynamic effects of compounds with unclear brain functional effects like antipsychotics. Methods: Data were derived from a general population adolescent and young adult twin sample. The total sample included 638 participants (Monozygotic = 202, Dizygotic = 436). ESM variables were randomly measured at 10 times/day over 6 consecutive days. For the main analyses, we assessed ESM information on PE (suspiciousness, loss of control, racing thoughts, pervasive thoughts, difficulties to express thoughts), NA (feeling lonely, anxious, listless, down, guilty), and event-related stress (pleasantness of the most important event since last entry); and for additional explorative analyses we assessed social stress (participants were asked with whom they are (e.g. nobody or family) and to rate the pleasantness of the social situation). PRS were trained on the results from the Psychiatric Genetics Consortium-2 SZ. Multilevel regression analyses, taking into account of multiple observations nested within twins who were clustered within family, were used to analyze the moderating effects of PRS (at p-value < 0.05) on the relationship between momentary stress and NA or PE. All analyses were adjusted for age, sex and 2 principle components. Discussion: This is the first study investigating the influence of molecular genetic risk for schizophrenia on momentary stress reactivity, measured using an ecologically valid diary method. These results suggest that PRS for schizophrenia does not have an effect on psychotic stress responses, while increased genetic risk for schizophrenia showed a buffering effect on the association between momentary stress and NA. Background: The Clinical Record Interactive Search (CRIS) database provides anonymised data from the full electronic health records of all patients at the South London and Maudsley NHS Foundation Trust, a large provider of secondary mental health care. We have previously shown how the large volumes of available CRIS data pertaining to outcomes can be mined and integrated with patient data collected by historical research interview. The applications of this futuristic translational research model are yet to be fully explored. The aim of this study is to determine whether transcriptomic profiles at the onset of psychosis can discern the likely trajectory symptoms over the subsequent 5 years of illness. Methods: The study sample consists of 200 first-episode psychosis cases (ICD-10 codes: F20-F29 or F30-F33) aged 18-65 years who presented to SLAM (South London and Maudsley NHS Trust) mental health services between the 1st of January 2010 and the 1st of January 2015. Patients were subsequently recruited to the GAP study. Patients were followed-up electronically for 5 years post recruitment using the CRIS research platform. RNA samples were collected at the baseline timepoint via PAXgene blood tubes and interrogates, using the Illumina HumanHT-12.v4 beadchip array. Samples were run at the National Institute for Health Research's (NIHR) Biomedical Research Centre for Mental Health (BRC-MH) at the Institute of Psychiatry, Psychology and Neuroscience. A total of 4756 probes passed a stringent quality control across the 200 samples. Results: CRIS data pertaining to the GAP cohort was interrogated for information on clinical symptoms over a 5-year period using text-mining and natural language processing apps that represent over 70 different dictionary definitions of psychotic and affective symptoms. Confirmatory factor analysis was used to reduce this to a much smaller set of orthogonal symptom dimensions which were then the subject of a genetic interrogation using gene expression data. The analysis was conducted using a statistical learning framework which combines Elastic net penalised regression methodology with K-fold cross-validation (via the GLMnet package in R). This identified gene transcripts that were predictive of longer term symptom trajectories in half of the available sample. The veracity of the model was further validated using the second withheld portion of the sample. Discussion: The results of this discovery phase may provide a rationale for subsequent multi-modal investigations whose aims will be to further enrich the biomarker signature and to also understand the molecular mechanisms that sustain them. Background: Infections are one of the major disease burdens internationally; however, the genetic architecture of infections is largely unknown. The human leukocyte antigen (HLA) loci have been implicated in susceptibility for infections; however, to date, largescale HLA type and genome wide association studies (GWAS) of infections have been lacking. We aim to investigate the genetic architecture of infections with GWAS of singlenucleotide polymorphisms (SNPs) and HLA types, including associations with mental disorders. Methods: We conducted case-cohort association analysis using both SNP's and HLA types from a Danish population-based sample born after 1981 comprising of 65.534 unrelated Danish individuals. All individuals were linked utilizing nationwide population-based registers with virtually complete registration of all hospital contacts for infections from birth, where 28.472 (43%) individuals had ≥1 infection requiring hospitalization. Among the 45.889 cases with mental disorders, a total of 21.728 (47%) cases had hospitalizations for infections, whereas among the 19.645 individuals with no severe mental disorders, a total of 6.744 (34%) cases had hospitalizations for infections. All analyses were adjusted for age, sex, and principal components. Results: We will present GWAS findings of the overall susceptibility for acquiring infections among individuals with severe mental disorders exploring differences to population controls. Furthermore, we will present SNP heritability of acquiring infections among individuals with severe mental disorders exploring differences to population controls. Moreover, we will present findings from association analysis of HLA types investigating the role of HLA alleles in susceptibility to infections and mental disorders. Lastly, we will present results on possible gene-infection interaction regarding the risk of mental illness. Discussion: Our findings will illuminate the genetic architecture of acquiring infections, and the genetic associations with mental disorders exploring the possible genetic component of the known association between infections and severe mental disorders, such as schizophrenia. Furthermore, we will for the first time in a large population based study explore the associations with HLA alleles to infections and severe mental disorders.
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